Cartesian Therapeutics, Inc. (RNAC): Shareholders' Equity
-$126.24M
As of 2025-12-31
-$125.23M
As of 2026-06-30
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$126.24M | n/m | 2026-03-09, Balance as of period end |
| 2024-12-31 | -$6.80M | n/m | 2026-03-09, Balance as of period end |
| 2023-12-31 | -$440.18M | n/m | 2025-03-13, Balance as of period end |
| 2022-12-31 | $93.83M | +316.6% | 2024-03-07, Balance as of period end |
| 2021-12-31 | $22.52M | n/m | 2024-03-07, Balance as of period end |
| 2020-12-31 | -$18.01M | n/m | 2023-03-02, Balance as of period end |
| 2019-12-31 | $8.40M | n/m | 2022-03-10, Balance as of period end |
| 2018-12-31 | -$5.42M | n/m | 2021-03-12, Balance as of period end |
| 2017-12-31 | $51.81M | -5.7% | 2020-03-12, Balance as of period end |
| 2016-12-31 | $54.96M | n/m | 2019-03-15, Balance as of period end |
| 2015-12-31 | -$116.49M | n/m | 2018-03-15, Balance as of period end |
| 2014-12-31 | -$87.75M | n/a | 2017-03-28, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Cartesian Therapeutics, Inc. (RNAC) | 2025-12-31 | -$126.24M | n/m |
| Upstream Bio, Inc. (UPB) | 2025-12-31 | $339.77M | -27.7% |
| Xenetic Biosciences, Inc. (XBIO) | 2025-12-31 | $7.40M | +23.1% |
| TherapeuticsMD, Inc. (TXMD) | 2025-12-31 | $26.88M | -1.8% |
| GeoVax Labs, Inc. (GOVX) | 2025-12-31 | $3.83M | -24.2% |
| Camp4 Therapeutics Corp (CAMP) | 2025-12-31 | $47.70M | -24.5% |
| Marker Therapeutics, Inc. (MRKR) | 2025-12-31 | $16.80M | -9.5% |
| Korsana Biosciences, Inc. (KRSA) | 2025-12-31 | $9.09M | +2.7% |
| Dianthus Therapeutics, Inc. (DNTH) | 2025-12-31 | $493.40M | +40.0% |
Compare RNAC, UPB, XBIO, TXMD side by side · Screen every company in Pharmaceutical Preparations ↗